Startups
Edit
http://providencetherapeutics.com/
Providence Therapeutics
TrustedLast activity: 29.09.2026
Active
Providence Therapeutics is a clinical-stage mRNA platform company developing vaccines for cancers and infectious diseases. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. We are building a portfolio of oncology vaccines while concurrently advancing our lead asset PTX-COVID19, a COVID-19 vaccine candidate, toward Phase 3 clinical trials. Additionally, we’re pursuing vaccine programs for infectious diseases that pose public health risks, including rabies. For more information, please visit providencetherapeutics.com.
Overview
Location
Canada
Employees
51-200
Total raised
$2.1M
Founded date
2015
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 5, 2026 | Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors | Leah Goodman brings a wealth of policy and regulatory experience and is a recognized leader in Australia for advancing scientific discoveries to patient impacts. CALGARY, AB and BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ -- Providence T... |
| Feb 4, 2026 | Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial | Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian c... |
| May 23, 2024 | Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics | CALGARY, AB and TORONTO, May 23, 2024 /PRNewswire/ -- Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and... |
| May 23, 2024 | Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics | CALGARY, AB and TORONTO, May 23, 2024 /PRNewswire/ - Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and ... |
| Dec 20, 2021 | Everest Medicines and Providence Therapeutics announces that PTX-COVID19-B, a mRNA Vaccine for COVID-19, has received approval for inclusion in WHO Solidarity Trial Vaccines (STV) Program | SHANGHAI, Dec. 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) and Providence Therapeutics ("Providence") announced today that their COVID-19 vaccine, PTX-COVID19-B, has been recommended by an independent advisory group ... |
| Dec 1, 2021 | Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant | SHANGHAI and CALGARY, Canada, Dec. 1, 2021 /PRNewswire/ -- Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifica... |
| Sep 13, 2021 | Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets | SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest" or the "Company") announced today two separate definitive agreements ("Agreements") with Providence Therapeutics Holdi... |
Reviews 0
FAQ about Providence Therapeutics
When was Providence Therapeutics founded?
Providence Therapeutics was founded in 2015.
How much funding has Providence Therapeutics raised?
Providence Therapeutics has raised $2.1M in total across 1 funding round.
What has the press written about Providence Therapeutics?
Parsers VC has collected 8 articles mentioning Providence Therapeutics, among them “Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors” (Feb 5, 2026) and “Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial” (Feb 4, 2026).
Is Providence Therapeutics still active?
Yes, Providence Therapeutics is active; its latest activity on Parsers VC dates from Sep 29, 2026.